These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27875522)

  • 21. (E)-2'-deoxy-2'-(fluoromethylene) cytidine potentiates radioresponse of two human solid tumor xenografts.
    Sun LQ; Li YX; Guillou L; Coucke PA
    Cancer Res; 1998 Dec; 58(23):5411-7. PubMed ID: 9850073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines.
    Miyamoto Y; Nakagawa S; Wada-Hiraike O; Seiki T; Tanikawa M; Hiraike H; Sone K; Nagasaka K; Oda K; Kawana K; Nakagawa K; Fujii T; Yano T; Kozuma S; Taketani Y
    Oncol Rep; 2013 Jan; 29(1):51-7. PubMed ID: 23064281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma.
    Kieran MW; Chisholm J; Casanova M; Brandes AA; Aerts I; Bouffet E; Bailey S; Leary S; MacDonald TJ; Mechinaud F; Cohen KJ; Riccardi R; Mason W; Hargrave D; Kalambakas S; Deshpande P; Tai F; Hurh E; Geoerger B
    Neuro Oncol; 2017 Oct; 19(11):1542-1552. PubMed ID: 28605510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activity of new combination chemotherapy with irinotecan hydrochloride and nedaplatin against human cervical cancer cell lines.
    Yamamoto K; Iwahana M; Kumazawa E; Kakihata K; Abe K; Hirano F; Tohgo A; Hoshiai H; Noda K
    Oncol Rep; 2003; 10(3):593-8. PubMed ID: 12684629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinomas unresponsive to either cisplatinum or anti-EGFR therapy can be growth inhibited by combination therapy of both agents.
    Knecht R; Peters S; Adunka O; Strebhardt K; Gstoettner W; Hambek M
    Anticancer Res; 2003; 23(3B):2577-83. PubMed ID: 12894544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced radiosensitization with interferon-alpha-2b and cisplatin in the treatment of locally advanced cervical carcinoma.
    Stock RG; Dottino P; Jennings TS; Terk M; DeWyngaert JK; Beddoe AM; Cohen C
    Gynecol Oncol; 1997 Dec; 67(3):309-15. PubMed ID: 9441780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia and metastasis in an orthotopic cervix cancer xenograft model.
    Chaudary N; Mujcic H; Wouters BG; Hill RP
    Radiother Oncol; 2013 Sep; 108(3):506-10. PubMed ID: 23856487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the CXCL12/CXCR4 pathway and myeloid cells to improve radiation treatment of locally advanced cervical cancer.
    Lecavalier-Barsoum M; Chaudary N; Han K; Koritzinsky M; Hill R; Milosevic M
    Int J Cancer; 2018 Sep; 143(5):1017-1028. PubMed ID: 29417588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signaling.
    Ibuki N; Ghaffari M; Pandey M; Iu I; Fazli L; Kashiwagi M; Tojo H; Nakanishi O; Gleave ME; Cox ME
    Int J Cancer; 2013 Oct; 133(8):1955-66. PubMed ID: 23564295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel neutralizing hedgehog antibody MEDI-5304 exhibits antitumor activity by inhibiting paracrine hedgehog signaling.
    Michaud NR; Wang Y; McEachern KA; Jordan JJ; Mazzola AM; Hernandez A; Jalla S; Chesebrough JW; Hynes MJ; Belmonte MA; Wang L; Kang JS; Jovanovic J; Laing N; Jenkins DW; Hurt E; Liang M; Frantz C; Hollingsworth RE; Simeone DM; Blakey DC; Bedian V
    Mol Cancer Ther; 2014 Feb; 13(2):386-98. PubMed ID: 24344235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
    Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of an EZH2 inhibitor in patient-derived orthotopic xenograft models of pediatric brain tumors alone and in combination with chemo- and radiation therapies.
    Qi L; Lindsay H; Kogiso M; Du Y; Braun FK; Zhang H; Guo L; Zhao S; Injac SG; Baxter PA; Su JM; Xiao S; Erickson SW; Earley EJ; Teicher B; Smith MA; Li XN
    Lab Invest; 2022 Feb; 102(2):185-193. PubMed ID: 34802040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
    Jorgensen TJ; Tian H; Joseph IB; Menon K; Frost D
    Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sonidegib for the treatment of advanced basal cell carcinoma: a comprehensive review of sonidegib and the BOLT trial with 12-month update.
    Chen L; Silapunt S; Migden MR
    Future Oncol; 2016 Sep; 12(18):2095-105. PubMed ID: 27189494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response.
    Sims-Mourtada J; Izzo JG; Apisarnthanarax S; Wu TT; Malhotra U; Luthra R; Liao Z; Komaki R; van der Kogel A; Ajani J; Chao KS
    Clin Cancer Res; 2006 Nov; 12(21):6565-72. PubMed ID: 17085672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized clinical trial of weekly versus triweekly cisplatin-based chemotherapy concurrent with radiotherapy in treatment of locally advanced cervical cancer: in regard to Ryu et al. (Int J Radiat Oncol Biol Phys 2011;81:e577-e581).
    Chakraborty S; Patil N
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1320-1. PubMed ID: 22385716
    [No Abstract]   [Full Text] [Related]  

  • 37. Hedgehog pathway signaling in cervical carcinoma and outcome after chemoradiation.
    Chaudary N; Pintilie M; Hedley D; Fyles AW; Milosevic M; Clarke B; Hill RP; Mackay H
    Cancer; 2012 Jun; 118(12):3105-15. PubMed ID: 22028038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I trial of erlotinib combined with cisplatin and radiotherapy for patients with locally advanced cervical squamous cell cancer.
    Nogueira-Rodrigues A; do Carmo CC; Viegas C; Erlich F; Camisão C; Fontão K; Lima R; Herchenhorn D; Martins RG; Moralez GM; Small IA; Ferreira CG
    Clin Cancer Res; 2008 Oct; 14(19):6324-9. PubMed ID: 18829516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer: in regard to Sang-Young Ryu et al. (Int J Radiat Oncol Biol Phys 2011;81:e577-e581).
    Goel S; Mitra S; Rawat S; Sharma SK; Sharma MK; Bhutani R; Kakria A
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1320. PubMed ID: 22385715
    [No Abstract]   [Full Text] [Related]  

  • 40. A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma.
    Shou Y; Robinson DM; Amakye DD; Rose KL; Cho YJ; Ligon KL; Sharp T; Haider AS; Bandaru R; Ando Y; Geoerger B; Doz F; Ashley DM; Hargrave DR; Casanova M; Tawbi HA; Rodon J; Thomas AL; Mita AC; MacDonald TJ; Kieran MW
    Clin Cancer Res; 2015 Feb; 21(3):585-93. PubMed ID: 25473003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.